Advancing genomic medicine for rare diseases in Africa
African Rare Diseases Initiative (ARDI): Advancing Genomic Medicine through rare diseases research in Africa
This study is all about finding out more about rare diseases in Africa, especially in the Democratic Republic of Congo, so we can better understand them and help patients get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Centre de Genetique Humaine NIH-funded |
| Lab location | 1 site (Lemba, Congo Dem Rep) |
| Project ID | NIH-11084532 on NIH RePORTER |
What this research studies
This research focuses on understanding and addressing rare diseases in Africa, particularly in the Democratic Republic of Congo. It aims to gather and analyze genomic data to identify the frequency and distribution of these diseases, which are often overlooked in global databases. By leveraging advancements in cloud technology and bioinformatics tools, the project seeks to improve diagnostic capabilities and patient care for those affected by rare diseases. The initiative also emphasizes the importance of community engagement and local advocacy in developing effective management strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in Africa, particularly those diagnosed with or suspected to have rare diseases.
Not a fit: Patients outside of Africa or those with common diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients with rare diseases in Africa.
How similar studies have performed: Previous research has shown that increasing local genomic data can significantly enhance understanding and treatment of rare diseases, indicating a promising approach in this initiative.
Where this research is happening
Lemba, Congo Dem Rep
- Centre de Genetique Humaine — Lemba, Congo Dem Rep (Active)
Researchers
- Principal investigator: Lumaka Zola, Aime — Centre de Genetique Humaine
- Study coordinator: Lumaka Zola, Aime
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.